Lupin launches generic Atovaquone Oral Suspension USP in US
Lupin has launched Atovaquone Oral Suspension USP, 750 mg/5 mL having received an approval from the United States Food and Drug Administration (USFDA) earlier. Lupin’s Atovaquone Oral Suspension USP, 750 mg/5 mL is the generic equivalent of Glaxosmithkline LLC’s Mepron oral suspension 750 mg/5 ml. It is indicated for the prevention of Pneumocystis jirovecii pneuomonia … Read more